The ACCROBAT I study: Three-year follow-up of a prospective phase II study with neoadjuvant TPF before bioradiotherapy for stage III-IV unresectable squamous cell head and neck cancer.

Clas Mercke,Helena Sjödin,Hedda Haugen,Gun Wickart-Johansson,Fernanda Costa Svedman,Gabriella von Dobeln,Gregori Margolin,Mats Hellström,Jan Nyman

The ACCROBAT I study: Three-year follow-up of a prospective phase II study with neoadjuvant TPF before bioradiotherapy for stage III-IV unresectable squamous cell head and neck cancer.

2014

Clas Mercke
Helena Sjödin
Hedda Haugen
Gun Wickart-Johansson
Fernanda Costa Svedman
Gabriella von Dobeln
Gregori Margolin
Mats Hellström
Jan Nyman

e17004 Background: Concomittant cisplatinbased chemoradiotherapy increases tumour control compared to radiation alone. However, both acute and late toxicity can be important and the influence on ra...

Keywords:

Physical therapy
General surgery
Head and neck cancer
Medicine
Phases of clinical research
Oncology
Chemoradiotherapy
late toxicity
Pathology
Cell
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations